HIV pharmacy specialty residency program in Canada

American Journal of Health-System Pharmacy

Volumn 58, Issue 7, 2001, Pages 591-594

  Tseng, A ^a   Foisy, M ^a   Bajcar, J ^a   Musing, E ^a   Wells, J ^a   Grondin, M ^a   Salit, I ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ARTICLE; BUDGET; CANADA; CAREER; DRUG INDUCED DISEASE; ERROR; HOSPITAL CARE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL EDUCATION; MEDICAL SPECIALIST; PHARMACY; PRESCRIPTION; PRIORITY JOURNAL; RESIDENCY EDUCATION; TREATMENT PLANNING;

EID: 0035313789     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.7.591     Document Type: Article

References (10)

1. Polypharmacy among patients attending an AIDS clinic: Utilization of prescribed, unorthodox, and investigational treatments
2. Prescribing errors with antiretroviral agents in HIV-infected patients
3. Hospitalization due to adverse drug reactions and drug interactions before and after HAART
4. Adherence to very active antiretroviral treatment: Impact of individualized assessment
5. Interventions and patient outcome from a pharmacist-based HIV medication adherence referral clinic
6. Maximising the benefits of HAART in the real world: The role of a pharmacist-led antiretroviral clinic
7. HIV pharmaceutical care specialist (PCS): An alternative model of care for patients with HIV
8. Outpatient pharmaceutical care is associated with an improved viral load response among patients on triple drug combination therapy
9. A pilot study of nelfinavir therapeutic drug monitoring in HIV-infected patients
10. Development of a post-Pharm.D. HIV specialty residency program